As one of the components of its Capacity Building and Access to Medicine project in Afghanistan, Health Partners International of Canada (HPIC) facilitated a two-day conference in Kabul in June 2011 to present the findings of its Pharmaceutical Manufacturing Assessment Study.
The results were shared with private and public stakeholders in pharmaceutical manufacturing in Afghanistan, including the Acting Minister of Public Health, to identify the next steps needed to enhance the industry in the country.
Leadership and Direction, Processes and Laws, Communications, Capacity Building and Industry Standards were the five key topics identified in the assessment, and discussed among the 65 participants, in order to form a common vision for the sector and feasible strategies along with implementation plans.
Stakeholders came to an agreed-upon vision of seeing Afghanistan produce at least 30% of its needed essential quality pharmaceuticals inside the country over the next 10 years. The following outcomes were also reported in support of this long-term goal:
- Stakeholders agreed that political, economic and capacity building support would be required
- Opportunities for the private sector to work closely with the public sector were identified
- Various incentives for pharmaceutical manufacturing were agreed upon
- The need to establish communications channels and dissemination of information inside and outside the country
- Committees should be established to develop and implement industry standards and processes to ensure international guidelines are established
- The development and establishment of skill building process is required.
Greater and more equitable access to priority medicines and medical supplies for Afghans, especially women and children, is the goal of HPIC’s Capacity Building and Access to Medicines project in Afghanistan. The multi-year development project is in partnership with the Afghan Ministry of Public Health and is funded by the Canadian International Development Agency.